Tillman Hartley LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Sell
334
-113
-25% -$115K 0.09% 65
2026
Q1
$411K Sell
447
-259
-37% -$263K 0.1% 63
2025
Q4
$759K Buy
706
+79
+13% +$75.5K 0.19% 54
2025
Q3
$478K Sell
627
-68
-10% -$50.6K 0.12% 62
2025
Q2
$542K Buy
695
+93
+15% +$72.3K 0.15% 61
2025
Q1
$497K Hold
602
0.14% 53
2024
Q4
$465K Sell
602
-16
-3% -$13.2K 0.13% 55
2024
Q3
$548K Hold
618
0.16% 48
2024
Q2
$560K Hold
618
0.19% 48
2024
Q1
$481K Hold
618
0.17% 47
2023
Q4
$360K Hold
618
0.13% 54
2023
Q3
$332K Hold
618
0.14% 53
2023
Q2
$290K Buy
618
+35
+6% +$14.7K 0.12% 63
2023
Q1
$200K Hold
583
0.09% 75
2022
Q4
$213K Buy
+583
New +$207K 0.09% 73

Other funds holding LLY

Tillman Hartley LLC's LLY Position: Q2 2026 in Review

Tillman Hartley LLC reduced its Eli Lilly (LLY) stake by 25% in Q2 2026, selling an estimated $115K and leaving 334 shares worth $401K. The position accounts for 0.09% of the portfolio, ranked #65.

Tillman Hartley LLC first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $759K in Q4 2025. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tillman Hartley LLC held 334 shares of Eli Lilly worth $401K as of Q2 2026.
  • Tillman Hartley LLC sold 113 Eli Lilly shares in Q2 2026, an estimated $115K.
  • Eli Lilly made up 0.09% of Tillman Hartley LLC's portfolio in Q2 2026, its #65 holding.
  • Tillman Hartley LLC first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • Tillman Hartley LLC's Eli Lilly position peaked at $759K in Q4 2025.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tillman Hartley LLC's 13F filing for Q2 2026, filed 6 Aug 2026.